Nih
Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
NIH PA-26-001: Administrative Supplements to Existing NIH Grants and Cooperative Agreements
NIH’s PA-26-001 is an open parent supplement program for current NIH-funded investigators that supports additional funding within the scope of an active award when unforeseen costs or opportunities require short-notice budget additions.
NIH PA-27-101: SBIR Phase IIB Strategic Breakthrough Award
The NIH PA-27-101 parent funding opportunity supports previous NIH SBIR and STTR Phase II recipients with a follow-on, commercially-focused Phase IIB award, provided each application includes required 100% third-party matching funds.
NIH PAR-25-370: ELSI Small Research Grant (R03 Clinical Trial Optional)
NIH NOFO PAR-25-370 supports small, self-contained ethical, legal, and social implications (ELSI) projects in human genetics and genomics with up to $50,000 direct costs per year and up to two years of support.
NIH PRIMED-AI Model-to-Clinic Grant 2027: Up to $1 Million a Year for Clinical AI Tools
NIH Common Fund's PRIMED-AI Model-to-Clinic opportunity supports image-centered, multimodal clinical decision-support tools moving from validated prototypes into clinical use, with applications due October 19, 2026.
NIH Quantum Computing Challenge
A two-stage NIH Qu-BIT prize competition for teams developing biomedical use cases in quantum computing, with up to US$1,300,000 in cash awards across stages.
NIH Quantum Sensing Technology Challenge
Historical reference for the completed NIH prize competition led by NCATS to adapt existing quantum-enabled sensing technologies for biomedical and clinical use cases.
NIH R01 Clinical Trial Required Parent NOFO (PA-25-305): 2026/2027 Guide
Parent NIH Research Project Grant (R01) mechanism requiring a clinical trial, with recurring NIH submission cycles through mid-2028 and 2027 planning-relevant deadlines.
NIH RFA-CA-27-020: Advanced Development of Informatics Technologies for Cancer Research and Management (U24)
RFA-CA-27-020 invites advanced development and dissemination of emerging cancer informatics technologies through a U24 cooperative agreement, with NCI intending $2.6M in FY2027 for an estimated three awards and a maximum direct cost of $600,000 per project year.
NIH RFA-DA-25-024: High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
NIH NIDA RFA-DA-25-024 supports high-priority research at the intersection of HIV and substance use, including prevention, treatment, cure, and implementation work with R01 funding flexibility and clinical trials optional.
NIH RFA-DA-25-060: High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
NIH NIDA RM1 funding for interdisciplinary teams studying HIV and substance use, prioritizing ambitious team-based proposals with a single transformative goal and up to five years of support.